{
  "retracted": false,
  "timestamp": 1559347200000,
  "updates": [
    {
      "timestamp": 1558100567390,
      "identifier": {
        "doi": "10.1016/j.leukres.2019.04.006"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.leukres.2019.02.012"
  },
  "journal": "Leukemia Research",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib” [Leukemia Res. 79 (2019) 38–44]"
}
